Antibody-drug conjugates remain front and centre of the biopharma world. Following Enhertu’s historic agnostic approval in HER2-positive solid tumours and TIVDAK winning full approval, the field has ...

French drugmaker Sanofi has halted the development of its antibody-drug conjugate (ADC) tusamitamab ravtansine after the drug failed a phase 3 trial in non-small cell lung cancer (NSCLC). The drug, ...

The rapidly-improving speed and versatility of digital computers has mostly driven analogue computers out of use in modern systems, as has the relative difficulty of programming an analogue computer.

LED candles are neat, but they’re very suboptimal for wish-making: you can’t blow them out. Unless you take the circuit from ...